Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
First Tracks Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. The Company's clinical-stage pipeline includes Rosnilimab, a selective pathogenic T cell depleter, for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a blood dendritic cell antigen 2 (BDCA2) modulator. Rosnilimab is an IgG1 antibody that directly targets pathogenic T cells, such as activated Tph/Tfh and T effector cells, in the periphery or inflamed tissue. Rosnilimab is designed to selectively deplete pathogenic T cells while sparing non-pathogenic T cells, including naive T cells, to preserve overall immune function and restore immune homeostasis. Its molecules have applicability across a range of autoimmune and inflammatory diseases, including gastroenterology, rheumatology and other areas.
Find out what a historical investment in First Tracks Biotherapeutics Inc would be worth today using our TRAX stock calculator.
Buying TRAX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in First Tracks Biotherapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in TRAX
What is the ticker symbol of First Tracks Biotherapeutics Inc?
The ticker symbol for First Tracks Biotherapeutics Inc is TRAX.
How much is one share of TRAX?
One share of TRAX is valued at $44.46 as of 20 November 2026.
What is the market capitalisation of First Tracks Biotherapeutics Inc TRAX?
As of 20 November 2026 First Tracks Biotherapeutics Inc has a market cap of $1.87B.
What is the 52-week high for First Tracks Biotherapeutics Inc stock?
The First Tracks Biotherapeutics Inc 52-week high stock price is $54.78.
What is the 52-week low for First Tracks Biotherapeutics Inc stock?
The First Tracks Biotherapeutics Inc 52-week low stock price is $14.72.
Can I buy TRAX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy TRAX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in TRAX on Stake
Buy TRAX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of TRAX from only US$10 with fractional shares